Founded in 1969, Jewish General Hospital Foundation (JGHF) raises funds to support health care and research at Jewish General Hospital. The Montreal-based hospital is a tertiary-care, McGill University teaching hospital that trains around 22% of the university’s medical students.

In F2017, Jewish General Hospital Foundation allocated approximately 39% of total program spending to Jewish General Hospital’s patient care, 30% to renovations and equipment purchases, and 28% to research. The hospital admits 24,000 patients and trains 650 student nurses yearly. Some of the hospital’s capital projects supported in F2017 include the following: fully renovating and computerizing a nephrology centre; renovating and expanding the 6,000 square foot Pathology Laboratory; and opening the Department of Psychiatry’s Mental Health Education Centre, which includes 5 offices and 2 teaching rooms. In 2017, the foundation also supported equipment purchases, including a new, portable 3D ultrasound that measures urinary bladder volume; two handheld, portable diagnostic Spirometers; two mobile carts for bedside use in the emergency department; and a new, portable intraoral camera for the dentistry department to take digital diagnostics and show patients images of their mouths. Jewish General Hospital Foundation supports research by funding Lady Davis Institute, the research division of the hospital. Ongoing research at the institute covers cancer, epidemiology, HIV/AIDS, and psychosocial science. JGHF announced that its 2017 research LDI/TD Bank Scholarships supported six masters and PhD students.

Results and Impact: Jewish General Hospital Foundation reports ongoing financial support for a safety study of Intraoperative Radiation Therapy for treating early-stage breast cancer. The treatment delivers the full radiation treatment at the patient’s time of surgery with great precision, reducing treatment time from three to six weeks down to a few minutes. The treatment successfully treated 7 early-stage breast cancer patients, a skin cancer patient, and 20 colorectal cancer patients, and aims to treat 60 patients annually. In its Spring 2018 Newsletter, the foundation reports a study from Lady David Institute that found 153 new gene variants associated with bone mineral density loss, which is the strongest clinical risk factor for osteoporosis.

Jewish General Hospital Foundation is a Major 100 charity with donations and special event revenues of $55.5m in F2017.  Administrative costs are 4% of revenues. Fundraising costs are 14% of donations and special events revenues, falling significantly from 28% in F2015. For every dollar donated, 81 cents go to the cause, falling within Ci’s reasonable range for overhead spending. JGHF has total funding reserves of $174.0m that can cover its annual program costs for 6.4 years. Excluding donor-endowed funds of $109.2m, funding reserves can cover annual programs costs for 3.0 years.

This charity report is an update that has been sent to Jewish General Hospital Foundation for review. Changes and edits may be forthcoming.

Updated on July 16, 2018 by Joeyanne Cheung.